There is no evidence that retail pharmacy chains contributed to the opioid crisis, attorneys for three of the companies argued during opening statements.
Tagged with: drugs opioids pharmacy
Read More »October 5, 2021 Comments Off on Pharmacy companies blameless for opioid crisis, attorneys say
There is no evidence that retail pharmacy chains contributed to the opioid crisis, attorneys for three of the companies argued during opening statements.
Tagged with: drugs opioids pharmacy
Read More »October 4, 2021 Comments Off on Pharmacies face 1st trial over role in opioid crisis
In a bellwether federal trial, two Ohio counties will try to convince a jury that retail pharmacy companies played an outsized role in the ongoing opioid crisis.
Read More »September 29, 2021 Comments Off on Appeals mounting in Purdue Pharma bankruptcy settlement
Objections to a historic settlement with Purdue Pharma are mounting, with one attorney general saying the plan doesn't hold the OxyContin maker or its owners accountable.
Tagged with: opioids purdue pharma
Read More »September 20, 2021 Comments Off on Plan to use OxyContin profits to fight opioids formally approved
A judge formally approved a plan to turn OxyContin maker Purdue Pharma into a new company with its profits going to fight the opioid epidemic.
Tagged with: drugs opioids oxycontin
Read More »September 7, 2021 Comments Off on $26B settlement of opioid lawsuits to move ahead after drug companies’ agreement
Four drug companies said enough states had agreed to a settlement of lawsuits over the opioid crisis for them to move ahead with the $26 billion deal.
Tagged with: opioids
Read More »September 2, 2021 Comments Off on ‘It’s done, just like our children’s lives’: Opioids settlement leaves families angry, conflicted
The prospect of families who lost loved ones in the opioid crisis facing OxyContin maker Purdue Pharma and its owners in a courtroom all but vanished Wednesday.
Tagged with: drugs opioids oxycontin
Read More »September 1, 2021 Comments Off on Purdue Pharma opioid settlement wins conditional approval over objections from Md., others
A federal judge gave conditional approval to a sweeping plan to settle a mountain of lawsuits over OxyContin maker Purdue Pharma's role in the opioid crisis.
Tagged with: Bankruptcy opioids oxycontin
Read More »August 23, 2021 Comments Off on Senators question FDA on work with opioid maker consultant
Several U.S. senators are questioning the Food and Drug Administration’s work with a consulting firm that helped businesses sell prescription painkillers during the nation's overdose crisis.
Tagged with: FDA opioids overdoses senate
Read More »August 23, 2021 Comments Off on OxyContin maker’s attorney warns of long, expensive litigation
An attorney for Purdue Pharma said a judge needs to accept its plan to settle thousands of lawsuits over the opioid epidemic or face “years or decades of Hobbesian hell” with complicated litigation.
Tagged with: opioids oxycontin
Read More »August 18, 2021 Comments Off on Ex-head of Purdue Pharma denies responsibility for opioid crisis
The former president and board chair of Purdue Pharma told a court Wednesday that he, his family and the company are not responsible for the opioid crisis in the United States.
Read More »